Letter: changes in FIB-4 cut-off points for viral hepatitis

被引：2
|
作者：
Kayadibi, H. [1 ]
机构：
[1] Hitit Univ Sch Med, Dept Med Biochem, Corum, Turkey
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2017年 / 45卷 / 07期
关键词：
D O I：
10.1111/apt.13956
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1007 / 1008
页数：2
相关论文
共 50 条
  • [1] Letter: changes in FIB-4 cut-off points for viral hepatitis - authors' reply
    Surana, P.
    Takyar, V.
    Koh, C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 1008 - 1009
  • [2] Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection
    Kayadibi, Huseyin
    Yasar, Bulent
    Ozkara, Selvinaz
    Demirpek, Ugur
    Uyanik, Metin
    Sertoglu, Erdim
    Ozcelik, Fatih
    Gonen, Can
    Aksaray, Sebahat
    [J]. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2017, 42 (01): : 51 - 57
  • [3] The optimal cut-off points of FIB-4 index for predicting the incidences of HCC and extra-hepatic malignancies in biopsyproven Japanese NAFLD patients
    Ito, Takanori
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Fujishiro, Mitsuhiro
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E775 - E775
  • [4] FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)
    Wu, Yinlian
    Kumar, Rahul
    Huang, Jiaofeng
    Wang, Mingfang
    Zhu, Yueyong
    Lin, Su
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 247 - 248
  • [5] Reply to: "FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)"
    Tsochatzis, Emmanuel A.
    Srivastava, Ankur
    Rosenberg, William
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 248 - 249
  • [6] DO WE NEED A NEW CUT-OFF FOR FIB-4 IN THE METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE ERA?
    Ahn, Sang Bong
    Park, Huiyul
    Yoon, Eileen
    Jun, Dae Won
    An, Ji Hyun
    Sohn, Joo Hyun
    Kim, Mimi
    Kang, Bo-Kyeong
    Lee, Chul-Min
    [J]. HEPATOLOGY, 2021, 74 : 1005A - 1005A
  • [7] Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?
    Park, Huiyul
    Yoon, Eileen L.
    Cho, Seon
    Nah, Eun-Hee
    Jun, Dae Won
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 (03) : 725 - 726
  • [8] Cut-off points for the rational believer
    Lissia, Lina Maria
    [J]. SYNTHESE, 2022, 200 (02)
  • [9] Cut-off points for the rational believer
    Lina Maria Lissia
    [J]. Synthese, 2022, 200
  • [10] FIB-4 cut-off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease
    Shah, Samir
    Dhami-Shah, Hiteshi
    Kamble, Swati
    Shukla, Akash
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 216 - 217
12345